The invention relates to a group of new substituted 1,7-annelated 1H-indazole derivatives being strong and selective antagonists of "neuronal" 5-hydroxytryptamine (5-HT) receptors.
The compounds can be represented by general formula 1:
本发明涉及一组新的取代 1,7-chanated 1H-indazole 衍
生物,它们是 "神经元 "5-羟
色胺(5-HT)受体的强效选择性拮抗剂。
这些化合物可由通式 1 表示: